ArriVent BioPharma, Inc. Common Stock
HealthcareNASDAQ:AVBP · NASDAQ Global Market
+$0.34 today
Vol 0.43M · Avg 0.49M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+31.24%
Period High
$33.09
Period Low
$16.95
Latest
$30.54
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Erasca, Inc.
NASDAQ:ERAS
$4.37B
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Iovance Biotherapeutics, Inc.
NASDAQ:IOVA
$1.46B
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX
$1.19B
MeiraGTx Holdings plc
NASDAQ:MGTX
$888.13M
Replimune Group, Inc.
NASDAQ:REPL
$733.24M
Astria Therapeutics, Inc.
ATXS
$718.13M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$515.41M
Valneva SE
NASDAQ:VALN
$507.78M
Arvinas, Inc.
NASDAQ:ARVN
$489.07M
What is the latest AVBP filing?
The latest filing shown is 8-K dated May 11, 2026.
How many recent filings does AVBP have?
Intrinsic Alpha currently shows 20 recent filings for AVBP.
Explore More
Continue the stock analysis
Jump to another research area for this company.